Zingiberen newsaponin
Zingiberen Newsaponin (Zingiberensis newsaponin) is an orally active type of steroid saponin compound. Zingiberen Newsaponin exerts anti-hepatocellular carcinoma (HCC) effects by inhibiting autophagy and the AKR1C1/JAK2/STAT3 pathway. Zingiberen Newsaponin activates oxidative stress (upregulates ROS and MDA) and mitochondrial pathways, promoting cancer cell apoptosis. Zingiberen Newsaponin alleviates cerebral ischemia-reperfusion (I/R) injury by decreasing the concentration of pro-inflammatory cytokines and inhibits NF-κB. Zingiberen Newsaponin can enhance the activity of SOD, eliminate free radicals and protect nerve cells. Zingiberen Newsaponin induces platelet aggregation[1][2][3].
Product Specifications
CAS Number
[91653-50-8]
Product Name Alternative
Zingiberensis newsaponin
UNSPSC
12352005
Target
Aldose Reductase; Apoptosis; Autophagy; JAK; NF-κB; Reactive Oxygen Species (ROS) ; SOD; STAT
Type
Natural Products
Related Pathways
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/zingiberen-newsaponin.html
Purity
99.68
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
Molecular Formula
C51H82O22
Molecular Weight
1047.18
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items